Cargando…

Utilizing CD30 expression as a rational target for therapy of lymphoma

Detalles Bibliográficos
Autor principal:	Kim, Won Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337265/ http://dx.doi.org/10.1186/1756-8722-5-S1-A2

Ejemplares similares

Towards rational engineering of cells: Recombinant gene expression in defined chromosomal loci
por: Nehlsen, Kristina, et al.
Publicado: (2011)

HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence, outcome, and evolution of CD4+ T cell lymphocytes
por: Egger, Matthias
Publicado: (2010)

From rationing to rationality: an n-of-one trial service for off-label medicines for rare (neuromuscular) diseases
por: Weinreich, Stephanie S, et al.
Publicado: (2012)

2718. Prevalence of Infections Following Anti-CD30 Targeted Chimeric Antigen Receptor T-cell Therapy for Relapsed and Refractory Lymphoma
por: Mohnasky, Michael C, et al.
Publicado: (2023)

Rational design of a PKA-based sensor for cGMP
por: Lorenz, Robin, et al.
Publicado: (2015)

CD133-regulated nucleophosmin expression in human colon cancer cells
por: Kim, Kun, et al.
Publicado: (2014)

Microbiome analysis in a pediatric cohort of inflammatory bowel disease supports the rational of fecal microbiome therapy
por: Doganci, Aysefa, et al.
Publicado: (2014)

Differential effect of corticosteroid therapy on the cytoplasmic cytokine expression in CD4 and CD8 positive T cells from lupus patients
por: Kiss, E, et al.
Publicado: (2001)

Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies
por: Okosun, Jessica, et al.
Publicado: (2013)

Identification of a putative new therapeutical target for Hodgkin's lymphoma
por: Kewitz, Stefanie, et al.
Publicado: (2015)

Psychometric properties of the Metacognitions Questionnaire-30 (MCQ-30) in a Greek sample
por: Typaldou, Maria, et al.
Publicado: (2010)

Rational discovery of new capsaicin analogues as TRPV1 activators
por: Cáceres, Javier, et al.
Publicado: (2015)

Targeting HTLV-I latency in Adult T-cell Leukemia/Lymphoma
por: Ramos, Juan C, et al.
Publicado: (2011)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
por: Barth, E, et al.
Publicado: (2000)

Nonlinear Burkitt lymphoma risk patterns with age and CD4 lymphocyte count among persons with AIDS in the United States
por: Guech-Ongey, Mercy, et al.
Publicado: (2010)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Obstacles to Anti-CD4 Therapy in Rheumatoid Arthritis
por: Kalden, Joachim R, et al.
Publicado: (2000)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
por: Nayar, Utthara, et al.
Publicado: (2010)

CD95 ligand expression in dedifferentiated breast cancer
por: Moers, C, et al.
Publicado: (2001)

Inverse correlation between Tax and CD25 expressions in HTLV-1 infected CD4 T-cells in vivo
por: Tezuka, Kenta, et al.
Publicado: (2011)

Enhanced protein synthesis and secretion using a rational signal-peptide library approach as a tailored tool
por: Stern, Beate, et al.
Publicado: (2011)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
por: Wang, Yucai, et al.
Publicado: (2018)

Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
por: Kim, Hee Kyung, et al.
Publicado: (2015)

Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
por: Major, Ajay, et al.
Publicado: (2023)

CD95 ligand expression mediates immune escape in breast cancer
por: Moers, C, et al.
Publicado: (2001)

Gene expression and glycan profiling of CD4+T cells in HAM/TSP
por: Kodama, Daisuke, et al.
Publicado: (2011)

CD3e expression in HTLV-1-infected individuals is associated with proviral load and Tax expression
por: Pinto, Mariana Tomazini, et al.
Publicado: (2011)

Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
por: Lanoy, E, et al.
Publicado: (2010)

The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30-II mRNA
por: Choudhary, Gunjan, et al.
Publicado: (2011)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

CD31 expression by cells of extensive ductal in situ and invasive carcinomas of the breast
por: Sapino, A, et al.
Publicado: (2001)

Abnormal gene expression in CD8 T cells from the lungs of scleroderma patients
por: Luzina, IG, et al.
Publicado: (2002)

Developing innovative targeted therapies for China
por: Jallal, Bahija
Publicado: (2012)

The new B-cell-specific exon 1B of the CD5 mRNA favors autoimmunity by preventing the membrane expression of CD5
por: Renaudineau, Y, et al.
Publicado: (2003)

The pathogenesis of osteoarthritis: potential targets for therapy
por: Abramson, S
Publicado: (2001)

Annual Scientific Meeting, Edmonton, September 27-30, 2007
Publicado: (2007)

30-year experience of Fontan surgery: single-centre's data
por: Bezuska, Laurynas, et al.
Publicado: (2015)

What we learned from bench to bedside with the neuroblastoma targeting CD171-specific CAR
por: Künkele, A, et al.
Publicado: (2015)

Primary breast lymphoma and MRI
por: Pedana, N, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sigbmtl8icpmh3602c97rsqo7v